Today
@today·5M subscribers·54.4K videos
Wegovy, Ozempic maker to face off on Capitol Hill over high prices
Posted
September 24, 2024
Views
2,139
Likes
36
Comments
8
Engagement
2.06%
September 24, 2024
2,139
36
8
2.06%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
3:14Now PlayingIn a new push to make popular weight loss drugs more affordable, the CEO of Novo Nordisk is set to face a grilling on Capitol Hill over the high cost of Ozempic, used to treat type 2 diabetes, and Wegovy which is approved for weight loss. NBC’s Christine Romans reports for TODAY.
» Subscribe to TODAY
About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.
Connect with TODAY Online!
Visit TODAY's Website
Find TODAY on Facebook
Follow TODAY on Twitter
Follow TODAY on Instagram
» Stream TODAY All Day
About: TODAY All Day is a 24/7 streaming channel bringing you the top stories in news and pop culture, celebrity interviews, cooking, and more. All in one place.
#weightloss #ozempic #drugs
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
